Seleeke Flingai to Immunotherapy
This is a "connection" page, showing publications Seleeke Flingai has written about Immunotherapy.
Connection Strength
0.105
-
Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy. Sci Rep. 2015 Jul 29; 5:12616.
Score: 0.085
-
A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes. Hum Gene Ther. 2014 Aug; 25(8):730-9.
Score: 0.020